GlassScriptPhysician profile
Chrisovalantis Lakhiani
NPI 1871937672
$7,274.71
in general payments reported to CMS, 2019-2025
15 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $715 · 2023: $1,233 · 2024: $4,983 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,550 · Food and Beverage: $2,122 · Travel and Lodging: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,550.00 |
| Food and Beverage | $2,121.82 |
| Travel and Lodging | $733.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $4,767.14 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $1,444.52 | 2022-2025 | |
| Sientra, INC. | $411.76 | 2021-2022 | |
| Abbott Laboratories | $190.90 | 2024 | Proclaim, Eterna |
| Medtronic, INC. | $183.68 | 2024 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $61.25 | 2022-2023 | Trumatch, Matrixmidface |
| Bioventus LLC | $38.21 | 2024-2025 | Stimrouter Implantable Kit |
| Pacira Pharmaceuticals Incorporated | $32.87 | 2023-2024 | Exparel, Iovera |
| Smith+Nephew, INC. | $28.01 | 2025 | Pico 7 |
| Solventum Corporation | $22.70 | 2024 | Prevena, V.A.C. Veraflo |
| Avita Medical Americas, LLC | $22.40 | 2023 | Recell |
| Abbvie INC. | $20.81 | 2025 | |
| Kerecis Limited | $18.41 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $16.94 | 2025 | |
| Mentor Worldwide LLC | $15.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chrisovalantis Lakhiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.